Cancer · 1978 · 61 citations · 18 references
MedicineDermatologyOncologyCutaneous OncologyMetastasisTumor ImmunologyCancer ImmunotherapyCutaneous Metastatic DiseaseImmunotherapy For Skin CancerSystemic Therapy For Skin CancerImmune Function TestingLocal Disease ControlMelanoma ImmunotherapyMetastatic Melanoma To SkinMetastatic Melanoma TreatmentTherapeutic Efficacy Assessment
Eighteen patients with multiple recurrences of malignant melanoma without evident distant spread were randomly assigned to treatment with either intralesional Bacillus Calmette-Guerin (BCG) or intralesional dinitrochlorobenzene (DNCB). Both agents were able to destroy approximately 90% of the injected intradermal nodules. Intradermal disease was more easily obliterated than subcutaneous disease with intralesional treatment with either agent, and local control of satellitosis with elimination of all clinically evident tumor was achieved in the patients who had intradermal without subcutaneous satellitosis, regardless of whether the patient was receiving BCG or DNCB. The clinical courses of the treated patients were essentially the same. Although PHA reactivity was depressed, the patients in both groups were responsive to recall and melanoma skin test antigens, demonstrated leukocyte migration inhibition with melanoma antigen and were generally within normal limits when assayed for 29 degrees C E rosettes. Our study demonstrated a dramatic difference in toxicity between the two intralesional agents without a similar difference in therapeutic efficacy or immune testing.
18
A generalized Wilcoxon test for comparing arbitrarily singly-censored samples
E. A. Gehan · Biometrika · 1965 · 3.4K citations
Spontaneous Regression of Cancer
Tilden C. Everson · The Lancet · 1966 · 686 citations
Medicine, Oncology, Carcinogenesis +11
Measurement of Delayed Skin-Test Responses
Joseph E. Sokal · New England Journal of Medicine · 1975 · 506 citations
Life Sciences, Immunology, Oncology +10
Immunological factors which influence response to immunotherapy in malignant melanoma.
D L Morton, Frederick R. Eilber, R. A. Malmgren et al. · PubMed · 1970 · 466 citations
Medicine, Immunology, Oncology +14